LifeMD Historical Cash Flow
| LFMD Stock | USD 6.10 0.50 8.93% |
Analysis of LifeMD cash flow over time is an excellent tool to project LifeMD Inc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 18.4 M or Change In Working Capital of 13.3 M as it is a great indicator of LifeMD ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining LifeMD Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether LifeMD Inc is a good buy for the upcoming year.
LifeMD |
About LifeMD Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in LifeMD balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which LifeMD's non-liquid assets can be easily converted into cash.
LifeMD Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from LifeMD's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At present, LifeMD's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 12.8 M, whereas Change To Account Receivables is projected to grow to (2.8 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Begin Period Cash Flow | 41.3M | 4.0M | 33.1M | 34.8M | End Period Cash Flow | 4.0M | 33.1M | 35.0M | 36.8M |
LifeMD cash flow statement Correlations
Click cells to compare fundamentals
LifeMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
LifeMD cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (314.2K) | (409.8K) | (2.2M) | 764.3K | 675.7K | 709.5K | |
| Change In Cash | 8.1M | 32.1M | (37.4M) | 29.2M | 1.9M | 2.8M | |
| Stock Based Compensation | 18.7M | 12.1M | 13.7M | 12.5M | 12.2M | 12.8M | |
| Free Cash Flow | (12.5M) | (36.5M) | (35.8M) | 86.9K | 17.5M | 18.4M | |
| Change In Working Capital | 8.8M | 9.1M | (1.5M) | 4.9M | 12.6M | 13.3M | |
| Other Cashflows From Financing Activities | 6.3M | (444K) | 2.7M | (667.6K) | (684.8K) | (650.6K) | |
| Depreciation | 397.8K | 868.8K | 3.8M | 6.6M | 9.5M | 10.0M | |
| Other Non Cash Items | 19.6M | 2.1M | 5.8M | 5.4M | 1.9M | 2.9M | |
| Capital Expenditures | 398.1K | 3.4M | 12.9M | 8.7M | 11.5M | 12.1M | |
| Total Cash From Operating Activities | (12.1M) | (33.1M) | (22.9M) | 8.8M | 17.5M | 18.4M | |
| Change To Account Receivables | (551.0K) | 17.7K | (2.2M) | (2.4M) | (2.9M) | (2.8M) | |
| Net Income | (60.5M) | (61.3M) | (45.0M) | (20.6M) | (18.7M) | (19.7M) | |
| Total Cash From Financing Activities | 21.0M | 68.6M | (528.2K) | 29.1M | (4.1M) | (3.9M) | |
| End Period Cash Flow | 9.2M | 41.3M | 4.0M | 33.1M | 35.0M | 36.8M | |
| Begin Period Cash Flow | 1.1M | 9.2M | 41.3M | 4.0M | 33.1M | 34.8M | |
| Net Borrowings | 798.3K | 93.2K | (530.8K) | 2.7M | 3.1M | 3.3M | |
| Total Cashflows From Investing Activities | (100K) | (798.1K) | (3.4M) | (13.9M) | (12.5M) | (11.9M) | |
| Change To Operating Activities | (286.8K) | (289.7K) | (571.2K) | (25.1K) | (22.6K) | (23.7K) | |
| Change To Netincome | 430.5K | 35.9M | 15.7M | 18.0M | 20.6M | 11.3M | |
| Change To Liabilities | 2.2M | 10.3M | 9.5M | 3.1M | 3.6M | 4.1M | |
| Investments | (798.1K) | (3.4M) | (13.9M) | (8.3M) | (11.5M) | (11.0M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.53) | Revenue Per Share | Quarterly Revenue Growth 0.432 | Return On Assets | Return On Equity |
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.